Drupal.behaviors.print = function(context) {window.print();window.close();}>
Quidel Unveils Name of Pending POC MDx Platform; Restructures Licensing Deal for Key Tech
October 27, 2011
Quidel Unveils Name of Pending POC MDx Platform; Restructures Licensing Deal for Key Tech
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Quidel Continues to Advance Trio of MDx Initiatives; On Target to Complete All by End of '13
March 1, 2012 / PCR Insider
Quidel Obtains CE Mark for AmpliVue C. Difficile, Company's First Handheld MDx Test
March 29, 2012 / PCR Insider
With BioHelix Acquisition, Quidel Brings Isothermal Amplification Tech in House
May 9, 2013 / PCR Insider
Australian OEM Firm Axxin Readying Readers for Partners' Isothermal Amplification MDx Tests
May 3, 2012 / PCR Insider
BioHelix Gets FDA Nod for First Point-of-Care MDx Test
October 20, 2011 / PCR Insider